Delivery Order SPE2DB20D1100-SPE2DB25FZ01D

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.26 firm fixed-price delivery order is for the supply of CORLANOR 7.5 MG TABLET 60S, a medication used to treat heart failure. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,497.28 firm fixed-price delivery order is for the medication CORLANOR 5MG 60S, with a performance period through July 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,174.89. The contract is a firm fixed price, non-set-aside award, indicating open competition. The delivery order has an ultimate completion date of May 16, 2025. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CORLANOR 5 MG TABLET 60S. The contract has a ceiling value of $2,114.52 and an ultimate completion date of August 7, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.07 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORLANOR 7.5 MG TABLET 60S, a prescription medication. The award, valued at $2,151.89, is a Firm Fixed Price contract with an ultimate completion date of August 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,197.62, is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The award is not set aside and has an ultimate completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as a firm fixed price delivery order for the supply of Corlanor 5 mg tablets. The total ceiling value of the award is $2,114.52, with a period of performance through April 2, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,565.48, is for the delivery of the pharmaceutical product CORLANOR 5 MG TABLET 60S. The contract has an ultimate completion date of October 16, 2023 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,333.49 firm fixed-price delivery order is for the supply of 4565286034 CORLANOR 5 MG TABLET 60S, a cardiovascular medication. The contract has a period of performance through July 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FZ01D
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of CORLANOR 5 MG TABLET 60S. The Firm Fixed Price contract has a ceiling value of $5,507.29 and a period of performance through November 13, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award has no set-aside designation, indicating open competition.

Generated 2/11/25, 10:24 AM